21 May 2009
Individualization of immunosuppressive therapy
B D KahanAnn Transplant 2009; 14(1): 20-20 :: ID: 880272
Abstract
This "Meet the Professor" discussion session is divided into four segments:
pre-morbid donor features (5 minutes), pre-transplant morbid donor events
(5 minutes), pre-transplant characteristics of potential recipients (10 minutes), and post-transplant recipient events (15 minutes). Each section will include a brief presentation and questions. The pre-morbid donor features include age over 50 years, pharmacogenomics, kidney size, and concomitant diseases. The morbid donor events include the etiology of death, preretrieval pathophysiologic events and intraoperative events. The pretransplant recipient characteristics are gender, age, ethnicity, medical regimen, pharmacogenomics, unrecognized malignancy/infection, HLA mismatch, socioeconomic education level, donor source, and immune responder status. The post-transplant recipient events include cold ischemia time, concomitant drug therapies, complications, chronic allograft disease, rejection episodes and non-compliance. Literature citations will be provided and informal discussion offered after the session.
Keywords: immunosuppressive therapy
In Press
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
02 Apr 2024 : Original article
Liver Transplantation from Brain-Dead Donors with Hepatitis B or C in South Korea: A 2014-2020 Korean Organ...Ann Transplant In Press; DOI: 10.12659/AOT.943588
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860